Reporting by Karolina Tagaris, Angeliki Koutantou; editing by James MackenzieOur Standards: The Thomson Reuters Trust Principles. Gruber anticipates data from those trials will likely be available "late at the end of the year or beginning of 2022." However, he said Pfizer has data that indicates a fully-vaccinated person's current dosage could be highly effective "at least up to 6 months," and possibly more. "We obviously are very attentive to being deliberate and careful, as we move down in age," he said. He said it presented "an opportunity to get back to normal life."
Pfizer has data that indicates a fully-vaccinated person's current round bottom data from an efficacy trial.
( z0 have :ARG0 ( z1 company :name ( z2 name :op "Pfizer" ) ) :ARG1 ( z3 data :ARG0-of ( z4 indicate :ARG1 ( z5 data :ARG1-of ( z6 round ) :mod ( z7 bottom ) :poss ( z8 person :ARG1-of ( z9 vaccinate :degree ( z10 full ) ) ) :source ( z11 try :ARG1 ( z12 efficacy ) ) :time ( z13 current ) ) ) ) )
(z0 / have-03
    :ARG0 (z1 / company
              :name (z2 / name
                        :op1 "Pfizer"))
    :ARG1 (z3 / data
              :ARG0-of (z4 / indicate-01
                           :ARG1 (z5 / data
                                     :ARG1-of (z6 / round-06)
                                     :mod (z7 / bottom)
                                     :poss (z8 / person
                                               :ARG1-of (z9 / vaccinate-01
                                                            :degree (z10 / full)))
                                     :source (z11 / try-01
                                                  :ARG1 (z12 / efficacy))
                                     :time (z13 / current)))))
Pfizer has data that indicates a fully - vaccinated person 's current round bottom data from an efficacy trial .
z1 :name z2
z2 :op1 0
z0 :ARG0 z1
z0 :ARG1 z3
z3 :ARG0-of z4
z9 :degree z10
z8 :ARG1-of z9
z5 :mod z7
z5 :ARG1-of z6
z5 :time z13
z5 :poss z8
z4 :ARG1 z5
z11 :ARG1 z12
z5 :source z11